Market Overview

Family Dollar Responds To Icahn With Poison Pill

Related FDO
Dollar Store Headwinds Not Uprooting Deutsche From Dollar Tree Buy Rating
Bull And Bear Cases For Dollar Tree Ahead Of Q3 Earnings

Shares of Family Dollar (NYSE: FDO) and Dollar General (NYSE: DG) are flying higher after Carl Icahn announced a 9.39 percent position in Family Dollar.

Analysts across Wall Street are speculating on a merger between the firms; Jefferies speculates a deal could add $1.2 billion of synergies. Deutsche Bank, who is less optimistic about the completion of a deal, still thinks it is a serious possibility.

However, a merger is nowhere near an open and closed case. Management teams of the firms have been resistant to hedge fund activity in the past. Nelson Peltz tried to buy Family Dollar in 2011 for over $7 billion and take it private, but the company initiated a poison pill provision and fought against the purchase.

Related: Jefferies Thinks Family Dollar And Dollar General Merger Is Likely

Similar to the response to Peltz’s proposed takeover, Family Dollar has once again initiated a poison pill provision that will limit Icahn’s ownership at 10 percent. The press release announcing the poison pill states that it, “is not designed to prevent an offer to acquire the Company, but rather to allow the Board adequate time to consider any and all alternatives.”

Although the poison pill indicates that Family Dollar will push back against Icahn, shares did not respond to the announcement. Family Dollar shares are up 15.88 percent from Friday’s close to $70.14. Dollar General shares are up 11.62 percent to $64.73.

Posted-In: Carl Icahn Poison PillNews Hedge Funds General


Related Articles (FDO + DG)

View Comments and Join the Discussion!